These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33841814)

  • 41. A diet high in α-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats.
    Hanke D; Zahradka P; Mohankumar SK; Clark JL; Taylor CG
    Prostaglandins Leukot Essent Fatty Acids; 2013; 89(6):391-401. PubMed ID: 24140006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice.
    Jung F; Lippmann T; Brandt A; Jin CJ; Engstler AJ; Baumann A
    Eur J Nutr; 2020 Mar; 59(2):787-799. PubMed ID: 30879098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
    Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
    J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
    Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
    Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.
    Cho IJ; Oh DH; Yoo J; Hwang YC; Ahn KJ; Chung HY; Jeong SW; Moon JY; Lee SH; Lim SJ; Jeong IK
    Sci Rep; 2021 May; 11(1):9894. PubMed ID: 33972568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
    El-Deen RM; Heeba GH; Abdel-Latif RG; Khalifa MMA
    Fundam Clin Pharmacol; 2020 Jun; 34(3):353-364. PubMed ID: 31885103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
    Softic S; Cohen DE; Kahn CR
    Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease.
    Ma H; Cui F; Dong JJ; You GP; Yang XJ; Lu HD; Huang YL
    World J Gastroenterol; 2014 Oct; 20(40):14950-7. PubMed ID: 25356056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F; Rashidkhani B; Hekmatdoost A
    Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dimethyl dimethoxy biphenyl dicarboxylate attenuates hepatic and metabolic alterations in high fructose-fed rats.
    Morsy MA; Ibrahim MA; Abd-Elghany MI
    Toxicol Ind Health; 2016 Jan; 32(1):59-67. PubMed ID: 24021431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
    Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
    Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease.
    Jin R; Willment A; Patel SS; Sun X; Song M; Mannery YO; Kosters A; McClain CJ; Vos MB
    Int J Hepatol; 2014; 2014():560620. PubMed ID: 25328713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats.
    Vatner DF; Snikeris J; Popov V; Perry RJ; Rahimi Y; Samuel VT
    PLoS One; 2015; 10(10):e0140837. PubMed ID: 26485433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
    Ushio M; Nishio Y; Sekine O; Nagai Y; Maeno Y; Ugi S; Yoshizaki T; Morino K; Kume S; Kashiwagi A; Maegawa H
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E293-304. PubMed ID: 23715726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
    Vilà L; Rebollo A; Ađalsteisson GS; Alegret M; Merlos M; Roglans N; Laguna JC
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):32-40. PubMed ID: 21122807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.